The Authors Reply.
作者信息
Lumlertgul Nuttha, Siribumrungwong Monchai, Jaber Bertrand L, Susantitaphong Paweena
机构信息
Division of Nephrology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Department of Medicine, Lerdsin Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
出版信息
Kidney Int Rep. 2018 Oct 26;4(1):185-186. doi: 10.1016/j.ekir.2018.10.011. eCollection 2019 Jan.
Abstract
摘要
相似文献
1
The Authors Reply.作者回复。
Kidney Int Rep. 2018 Oct 26;4(1):185-186. doi: 10.1016/j.ekir.2018.10.011. eCollection 2019 Jan.
2
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.红外斩波副镜的像差：作者对评论2的回复以及对评论1回复的延续
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
3
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.作者回复：对作者回复的评论：患者对风险的认知：胎儿非整倍体产前检测中的知情选择。
Singapore Med J. 2013 Apr;54(4):238. doi: 10.11622/smedj.2013084.
4
Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.对塞内费尔德和亨特的回复：医学中的生理学：糖尿病性神经病变的神经肌肉后果。作者的回复。
J Appl Physiol (1985). 2016 Jul 1;121(1):361. doi: 10.1152/japplphysiol.00423.2016.
5
Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid: reply from the authors.回复：天疱疮和类天疱疮流行病学研究数据库检索策略的验证：作者的回复
Br J Dermatol. 2016 Mar;174(3):697. doi: 10.1111/bjd.14393. Epub 2016 Feb 16.
6
The Authors Reply: Reply on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".作者回复：对“证据足够吗？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网络荟萃分析”的回复。
Int Neurourol J. 2017 Sep;21(3):231-232. doi: 10.5213/inj.1734986.493. Epub 2017 Sep 12.
7
Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".回复：对作者对关于“用于预防心脏性猝死的可穿戴式心脏复律除颤器：一项卫生技术评估和患者焦点小组研究”的批判性评价的回复的评论
Med Devices (Auckl). 2019 Mar 22;12:129-131. doi: 10.2147/MDER.S202581. eCollection 2019.
8
Authors' Reply to the Letter to the Editor: Reply to "Cognitive performance in women with fibromyalgia' by de Heredia-Torres and colleagues".作者对致编辑信的回复：对德埃雷迪亚 - 托雷斯及其同事所著《纤维肌痛女性的认知表现》的回复
Aust Occup Ther J. 2017 Aug;64(4):E101. doi: 10.1111/1440-1630.12385.
9
Reply to 'Frontal Fibrosing Alopecia Severity Index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia': reply from the authors.对《额部纤维性秃发严重程度指数（FFASI）：一种用于评估额部纤维性秃发的有效评分系统》的回复：作者的回复
Br J Dermatol. 2016 Sep;175(3):648-9. doi: 10.1111/bjd.14859. Epub 2016 Jul 25.
10
Reply from the authors. Reply: SDD and contextual effect.作者回复。回复：选择性消化道去污和情境效应。
Br J Anaesth. 2015 Sep;115(3):480. doi: 10.1093/bja/aev267.
本文引用的文献
1
Successful Renal Transplantation after Presumed Cyanide Toxicity Treated with Hydroxocobalamin and Review of the Literature.经羟钴胺治疗疑似氰化物中毒后的成功肾移植及文献综述
Case Rep Transplant. 2018 Sep 9;2018:3753479. doi: 10.1155/2018/3753479. eCollection 2018.
2
Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients.危重症烧伤患者使用氰化物解毒剂羟钴胺素后发生草酸盐肾病的风险。
Intensive Care Med. 2016 Jun;42(6):1080-1. doi: 10.1007/s00134-016-4252-4. Epub 2016 Feb 18.
3
Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.羟钴胺素用于烟雾吸入所致急性氰化物中毒的前瞻性研究。
Ann Emerg Med. 2007 Jun;49(6):794-801, 801.e1-2. doi: 10.1016/j.annemergmed.2007.01.026. Epub 2007 May 4.
4
Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs.羟钴胺素对成年比格犬急性氰化物中毒的治疗效果。
Clin Toxicol (Phila). 2006;44 Suppl 1:5-15. doi: 10.1080/15563650600811672.
Zotero 插件